Search Within

Ingo K Mellinghoff

  1. "Dermatology Service"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Department of Medicine (6)
  2. Dermatology (6)
  3. Dermatology Service (6)
  4. Division of Subspecialty Medicine (6)
  5. GSK Faculty (6)
  6. Human Oncology and Pathogenesis Program (6)

More Groups

People
  1. Mario Lacouture (5)
  2. Andrew Lassman (4)
  3. Lisa De Angelis (4)
  4. Thomas Kaley (4)
  5. Antonio Omuro (3)
  6. Craig Nolan (3)

More People

Years
  1. 2020 (1)
  2. 2015 (1)
  3. 2014 (1)
  4. 2013 (1)
  5. 2012 (1)
  6. 2011 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Neuro-Oncology (2)
  3. Annals of Clinical and Translational Neurology (1)
  4. JAAD Case Reports (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Oxford University Press (2)
  3. Elsevier Inc. (1)
  4. Wiley Blackwell (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma
    Journal Article

    Kaley, T. J.; Panageas, K. S.; Pentsova, E. I.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I.; DeAngelis, L. M.; Abrey, L. E.; Holland, E. C.; Omuro, A.; more...
    Annals of Clinical and Translational Neurology (2020)

    Fulltext@MSK | Save
  • Cutaneous adverse drug reaction associated with oral temozolomide presenting as dermal and subcutaneous plaques and nodules
    Journal Article

    Virmani, P.; Chung, E.; Thomas, A. A.; Mellinghoff, I. K.; Marchetti, M. A.
    JAAD Case Reports (2015)

    Fulltext@MSK | Save
  • Clinical and histologic characterization of dermatologic adverse events front the pan-PI3K inhibitor buparlisib (BKM-120)
    Meeting Abstract

    Schindler, K.; Abraham, R.; Shah, P. D.; Chandarlapaty, S.; Paik, P. K.; Bell-Mcguinn, K.; Bajorin, D. F.; Mellinghoff, I. K.; Younes, A.; Gounder, M. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus (TEM) and perifosine (PER) for recurrent or progressive malignant glioma (MG)
    Meeting Abstract

    Kaley, T. J.; Pentsova, E.; Omuro, A. M. P.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I. T.; DeAngelis, L. M.; Lacouture, M. E.; Holland, E. C.; Lassman, A. B.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus (TEM) and perifosine (PER) for recurrent or progressive malignant glioma (MG)
    Meeting Abstract

    Kaley, T. J.; Pentsova, E.; Omuro, A.; Mellinghoff, I.; Nolan, C.; Gavrilovic, I.; Deangelis, L. M.; Holland, E.; Lacouture, M. E.; Ludwig, E.; more...
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus and perifosine for recurrent or progressive malignant glioma
    Meeting Abstract

    Lassman, A. B.; Kaley, T. J.; Deangelis, L. M.; Hormigo, A.; Mellinghoff, I. K.; Otap, D. D.; Seger, J.; Doyle, L. A.; Ludwig, E.; Lacouture, M. E.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save